Back to Journals » OncoTargets and Therapy » Volume 6
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
20,673 | Dovepress* | 14,794+ | 3,562 | 18,356 | |
PubMed Central* | 5,879 | 1,950 | 7,829 | ||
Totals | 20,673 | 5,512 | 26,185 | ||
*Since 5 November 2013 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
5 | 0 | 0 | 0 | 0 | 5 |
View citations on PubMed and Google Scholar